Clinical Trial Update: Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study [NA]

View source ↗

Summary

RADREMI was a prospective pilot study evaluating dose reduction of radiosurgery for brain metastases in patients receiving immunotherapy; the trial was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Metastases
• Brain Tumor

Snippet

Sponsor: Indiana University | Conditions: Brain Tumor, Brain Metastases | NA | Status: TERMINATED | Results posted: 2024-09-19